Careloop GmbH has been acquired by Klett Group
The founders and the investor consortium of Careloop GmbH have sold a majority stake to Klett Group in the next phase of their growth strategy.
Careloop is a technology driven end-to-end platform for healthcare groups to recruit, educate and retain international medical professionals. Active in the healthcare staffing market, Careloop has redesigned the recruitment of international medical professionals by digitizing the process and making it cost efficient and convenient for all parties. The company’s shareholders consisted of leading venture capital firms, such as IBB Ventures, Redstone and the Swiss Founders Fund, as well as the founders of the company and business angels.
The Klett Group is one of Europe’s leading educational companies, spanning sectors from early childhood education to adult learning and publishing. With operations in 18 countries, it fosters lifelong learning through tailored educational solutions. The company is also actively involved in recruiting foreign professionals, addressing the skills shortage and enhancing the education sector with global talent.
Oaklins’ team in Germany acted as the exclusive advisor to the shareholders and management of Careloop in the preparation of the sale process and due diligence, the approach and negotiations with the preferred buyer, and assisted them until closing.



Alexander Lundberg
Founder and CEO, Careloop
Sprechen Sie mit dem Deal Team
Transaktionen
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Mehr erfahrenCerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.
Mehr erfahreniwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Mehr erfahren